MYF6 Gene Centronuclear Myopathy Type 3 Genetic Test
Centronuclear myopathy type 3 is a rare genetic disorder characterized by muscle weakness and wasting. It is caused by mutations in the MYF6 gene, which is responsible for producing the myogenin protein. The MYF6 Gene Centronuclear myopathy type 3 Genetic Test offered by DNA Labs UAE aims to identify these mutations and confirm a diagnosis.
Test Details
The MYF6 Gene Centronuclear myopathy type 3 Genetic Test is performed using NGS (Next-Generation Sequencing) technology. This advanced sequencing method allows for the analysis of the DNA sequence of the MYF6 gene to identify any changes or mutations.
Test Components and Price
- Test Name: MYF6 Gene Centronuclear myopathy type 3 Genetic Test
- Price: 4400.0 AED
Sample Condition
The test requires a blood sample or extracted DNA. Alternatively, one drop of blood can be collected on an FTA card.
Report Delivery
The test results will be delivered within 3 to 4 weeks.
Test Type and Doctor
The MYF6 Gene Centronuclear myopathy type 3 Genetic Test falls under the category of Neurological Disorders. It is recommended to consult a Neurologist for this test.
Test Department
The MYF6 Gene Centronuclear myopathy type 3 Genetic Test is conducted in the Genetics department of DNA Labs UAE.
Pre Test Information
Prior to the test, it is important to provide the clinical history of the patient who is undergoing the MYF6 Gene Centronuclear myopathy type 3 NGS Genetic DNA Test. Additionally, a Genetic Counselling session is recommended to draw a pedigree chart of family members affected by MYF6 Gene Centronuclear myopathy type 3.
Signs and Symptoms
Centronuclear myopathy type 3 is characterized by muscle weakness and wasting. Individuals with this disorder may experience difficulties with movement, muscle stiffness, and delayed motor skills development.
Importance of Genetic Testing
The MYF6 Gene Centronuclear myopathy type 3 Genetic Test plays a crucial role in confirming a diagnosis and guiding treatment and management options for individuals with this rare genetic disorder. By identifying mutations in the MYF6 gene, healthcare professionals can provide personalized care and support to patients.
Test Name | MYF6 Gene Centronuclear myopathy type 3 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for MYF6 Gene Centronuclear myopathy type 3 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with MYF6 Gene Centronuclear myopathy type 3 |
Test Details |
The MYF6 gene is associated with centronuclear myopathy type 3, a rare genetic disorder characterized by muscle weakness and wasting. This disorder is caused by mutations in the MYF6 gene, which provides instructions for making a protein called myogenin. Myogenin is important for the development and function of muscle cells. NGS genetic testing can be used to identify mutations in the MYF6 gene. This type of testing uses advanced sequencing technology to analyze the DNA sequence of the gene and identify any changes or mutations. This information can be used to confirm a diagnosis of centronuclear myopathy type 3 and help guide treatment and management options. |